A composition for the prevention or treatment of angiogenesis- and cell proliferation-related disease processes
AUTHOR: Garrido, JM; Sánchez-Montesinos, I.
REGISTRY NO.: P200930321. PCT/ES2010/070403
PRIORITY DATE: 16/06/2009
HOLDER: University of Granada / Andalusian Public Health System
SUMMARY: SUMMARY: A composition comprising a statin and a vascular endothelial activating agent. This composition can be used to prepare medicinal products or pharmaceutical compositions preferably for the prevention or treatment of disease processes associated with abnormal cell proliferation and pathological or undesired angiogenesis such as cancer or arteriosclerosis.